1. A powder composition containing (i) finely divided particles with an average particle diameter of 20 μm or less, containing (i-1) a drug having a side effect of drug-induced photodermatosis, (i-2) an excipient and (ii) a carrier with an average particle diameter of 10 ~ 200 μm. 2. The powder composition of claim 1, wherein the drug having the side effect of drug induced photodermatosis is 1 or 2 or more selected from the group consisting of antibiotics, a drug against malignant tumors, an antiepileptic drug, an antidepressant, an antifungal drugs, antihistamines, antimalarials, anti-gout drugs, psychotropic drugs, medications I have a cardiovascular system, a diuretic, an anti-lipemic agent, a non-steroidal anti-inflammatory drug, a phototherapy drug, a retinoid and a drug for treating pulmonary fibrosis. 3. The powder composition according to claim 1, wherein the medicament having the side effect of the drug induced photodermatosis is an agent for treating pulmonary fibrosis. The powder composition according to claim 1, where the drug having the side effect of photodermatosis induced by the drug is pirfenidone. A powder composition according to any one of claims 1 to 4, wherein the finely divided particle and the carrier form a complex. The powder composition according to claim 5, where the diameter of the finely ground particles is less than the average particle diameter of the carrier. Powder1. Порошковый состав, содержащий(i) тонко измельченные частицы со средним диаметром частиц 20 мкм или менее, содержащих(i-1) лекарственное средство, обладающее побочным эффектом фотодерматоза, индуцируемого лекарственным средством,(i-2) эксципиент и(ii) носитель со средним диаметром частиц 10~200 мкм.2. Порошковый состав по п.1, где лекарственное средство, обладающее побочным эффектом фотодерматоза, индуцируемого лекарственным средством, представляет собой 1 или 2, или более, выбранных из группы, состоящей из антибиотиков, лекарственного средства против злокачественных опу
